Surgisphere Fallout Hits African Nonprofit’s COVID-19 Efforts

The company had helped develop a tool to aid decision-making in distributing limited medical equipment among coronavirus patients, but two high-profile retractions call into question the validity of Surgisphere’s work in toto.

| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

ABOVE: © ISTOCK.COM,
FIVEPOINTSIX

Update (June 8): Surgisphere’s online COVID-19 Response Center and the four web tools hosted on it have been taken down from the company’s website.

Anonprofit organization in Africa that promoted a tool to help clinicians determine how to allocate limited medical resources among COVID-19 patients is walking back its recommendations in the wake of a scandal involving the company that collaborated on the project.

Surgisphere Corporation, an Illinois-based company founded in 2008 by vascular surgeon Sapan Desai, has come under fire in recent days for failing to obtain independent validation for datasets used in two high-profile studies in The Lancet and the New England Journal of Medicine. Both papers are now retracted.

The Lancet study, which reported safety concerns about the use of the antimalarial drug hydroxychloroquine in coronavirus patients, led the World Health Organization to suspend part of a clinical trial. Testing resumed last week ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Conceptual 3D image of DNA on a blue background.

Understanding the Nuts and Bolts of qPCR Assay Controls 

Bio-Rad
Takara Bio

Takara Bio USA Holdings, Inc. announces the acquisition of Curio Bioscience, adding spatial biology to its broad portfolio of single-cell omics solutions

Sapio Sciences

Sapio Sciences Announces Enhanced Capabilities for Chemistry, Immunogenicity, GMP and Molecular Biology

Biotium Logo

Biotium Unveils the Most Sensitive Stains for DNA or RNA with New EMBER™ Ultra Agarose Gel Kits